Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Portal Vein Recanalization in Cirrhotic Patients with Acute Portal Vein Thrombosis: A Single-Center Study.

Ramalingam, Vijay, Zohaa Faiz, Mariam Dogar, Jeffrey Weinstein, Lauren Yang, Jonathan Berry, Michael Curry, Ammar Sarwar, and Muneeb Ahmed. 2026. “Outcomes of Transjugular Intrahepatic Portosystemic Shunt With Portal Vein Recanalization in Cirrhotic Patients With Acute Portal Vein Thrombosis: A Single-Center Study.”. Cardiovascular and Interventional Radiology.

Abstract

PURPOSE: This study aims to evaluate the safety and effectiveness of TIPS-PVR in patients with cirrhosis with acute PVT.

MATERIALS AND METHODS: A retrospective analysis of cirrhotic patients with acute PVT who underwent TIPS-PVR at a single academic institution. Patients were categorized by PVT etiology and thrombus extent according to AASLD criteria. Outcomes assessed included technical success, one-year patency of the TIPS and porto-mesenteric venous system, need for TIPS reintervention, symptom recurrence, and overall survival. Overall survival was defined as the time from TIPS-PVR to death or last follow-up.

RESULTS: Fifty cirrhotic patients underwent TIPS-PVR for acute PVT. Technical success was 100%. Superior mesenteric vein (SMV) involvement was seen in 30/50 (60%), and splenic vein in 11/50 (22%). At one year, 32 patients had follow-up. Primary patency was 75% (24/32), primary-assisted patency 94% (30/32) for TIPS and 97% (31/32) for the portal vein. Patency rates improved at one year: Main portal vein from 18 to 97% (p < 0.001), SMV from 50 to 91% (p < 0.001), splenic vein from 78 to 100% (p = 0.0108). 9 patients underwent liver transplantation after TIPS-PVR. There were no grade 4 or grade 5 CIRSE adverse events. There were five Grade 6 events after the procedure. Overall survival was 78% at 12 months, with 95% CI 64-87%.

CONCLUSIONS: TIPS-PVR appears to be a safe and effective procedure for cirrhotic patients with acute PVT, offering a viable option for restoring portal venous flow.

Last updated on 04/02/2026
PubMed